Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06784895 · ClinicalTrials.gov registry record · NA

Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program

A NA study of Cardiovascular Diseases and Cardiac Rehabilitation, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06784895: Recruiting NA study of Cardiovascular Diseases and Cardiac Rehabilitation, sponsored by University of Michigan.

NCT06784895 is a NA study of Cardiovascular Diseases and Cardiac Rehabilitation that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 60 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06784895, a NA study of Cardiovascular Diseases and Cardiac Rehabilitation, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled study is to investigate the effect(s) of a pilot women-only cardiac rehabilitation (CR) program. The study team will be testing the effectiveness, compliance and enjoyment of this women's only cardiac rehabilitation (CR) program by comparing outcomes to those randomized to receive Michigan Medicine's current CR program (standard care), which includes people of all genders. Study hypotheses: * Women randomized to women-specific CR programming will have superior attendance and completion rates compared to women attending mixed-sex CR programming. * Women randomized to women-specific CR programming will experience greater improvement in clinical outcomes in comparison to those in mixed-sex CR programming.

Primary Outcome

CR completion rate defined as number of patients that "graduated" or completed CR programming versus the number of patients that started CR programming \[i.e. attended 75% or more of the prescribed sessions (≥27 out of 36)\], expressed as a percentage of participants per arm.

Interventions

  • BEHAVIORAL Women only Cardiac Rehab program
  • BEHAVIORAL Standard of Care (mixed-sex) rehab program

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-05-05
Est. Completion 2027-03
Phase NA
University of Michigan

1,327 total trials

What NCT06784895 shows while recruiting

NCT06784895 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Women only Cardiac Rehab program is the first listed.

NCT06784895 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06784895 about?

NCT06784895 is a clinical study titled "Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program". The purpose of this randomized controlled study is to investigate the effect(s) of a pilot women-only cardiac rehabilitation (CR) program. The study team will be testing the effectiveness, compliance and enjoyment of this women's only cardiac rehabilitation (CR) program by comparing outcomes to thos...

What is the current status of trial NCT06784895?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-05. Estimated completion is 2027-03.

What conditions does trial NCT06784895 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Cardiac Rehabilitation.

What interventions are being tested in trial NCT06784895?

The interventions under investigation include: Women only Cardiac Rehab program (BEHAVIORAL), Standard of Care (mixed-sex) rehab program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06784895?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06784895 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06784895's enrollment target sits among peer trials

60 222nd of 300 higher than 69 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06784895, the US trial registry maintained by the National Library of Medicine. NCT06784895 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.